Framework agreement for in-vivo studies using mouse NB-PDX models
Charité – Universitätsmedizin Berlin is procuring a single-supplier framework agreement for in-vivo therapy, characterization or biodistribution/pharmacokinetic studies using patient-derived neuroblastoma xenograft models in mice, including collection of PDX tumour material. The term is 48 months, with a stated maximum of three 12-month renewals. Electronic offers are due 23 October 2026 at 10:00
08:00 AM · UTC
Contract value
Not stated in the notice
Classification
Pre-clinical research services
Published
September 22, 2026
Bekanntmachungsservice - öffentlichevergabe.de
Overview
Charité – Universitätsmedizin Berlin is procuring a single-supplier framework agreement for in-vivo therapy, characterization or biodistribution/pharmacokinetic studies using patient-derived neuroblastoma xenograft models in mice, including collection of PDX tumour material. The term is 48 months, with a stated maximum of three 12-month renewals. Electronic offers are due 23 October 2026 at 10:00 UTC+02:00 (08:00 UTC).
Information based on the public notice
Ask about this tender
What the buyer needs
Framework agreement for in-vivo studies using mouse NB-PDX models
Tender details
- Buyer
- Charité - Universitätsmedizin Berlin
- Country
Germany
- Procedure
- open
- Classification
- Pre-clinical research services · 73111000 · CPV 73110000
- Notice reference
- ocds-mnwr74-db3d3fea-1cf3-4ba7-92b0-3f833c6e0285
- Submission deadline
- Charité – Universitätsmedizin Berlin is procuring a single-supplier framework agreement for in-vivo therapy, characterization or biodistribution/pharmacokinetic studies using patient-derived neuroblastoma xenograft models in mice, including collection of PDX tumour material. The term is 48 months, with a stated maximum of three 12-month renewals. Electronic offers are due 23 October 2026 at 10:00
Original notice
Read the original description
Rahmenvertrag über In-Vivo-Studien an NB-PDX-Modellen in Mäusen
Rahmenvertrag über In-Vivo-Studien an NB-PDX-Modellen in Mäusen
Die Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin schreibt einen Rahmenvertrag über die Durchführung von In-Vivo-Studien (Therapie, Charakterisierung oder Bioverteilung/Pharmakokinetikstudien) an patientenabgeleiteten Neuroblastom-Xenograft-Modellen in Mäusen ("NB-PDX-Modellen") nebst Entnahme von PDX-Tumormaterial aus. Es handelt sich hierbei um einen Rahmenvertrag mit nur einem Auftragnehmer.
Es bestehen gesonderte Anforderungen nach dem Berliner Ausschreibungs- und Vergabegesetz (BerlAVG), siehe Vergabeunterlagen.
Nähere Informationen können den auf der Vergabeplattform der Charité (https://vergabeplattform.charite.de) zur Verfügung gestellten Unterlagen entnommen werden.
Offer submission deadline: 2026-10-23T10:00:00+02:00
Official source: Bekanntmachungsservice - öffentlichevergabe.de ↗
https://zephior.com/tenders/ce9df217-d452-4e61-97a5-71480d1ff47b/framework-agreement-for-in-vivo-studies-using-mouse-nb-pdx-models
https://oeffentlichevergabe.de/ui/de/notices/fcedf0f7-9efd-4e0f-999b-cb7eceb0c7f0
Source retrieved: 2026-10-14T07:40:21.760826Z
https://oeffentlichevergabe.de/ui/de/notices/fcedf0f7-9efd-4e0f-999b-cb7eceb0c7f0
Source retrieved: 2026-10-14T07:40:21.760826Z